Skip to content
Back to Guavy Wire
Stocks

Johnson & Johnson EVP Elizabeth Forminard Sells Shares Worth Over $4 Million

Instruments
JNJ
Share

Johnson & Johnson (NYSE:JNJ) executive vice president Elizabeth Forminard has sold 15,918 shares of company stock in a transaction dated August 6th. The shares were sold at an average price of $257.00, resulting in a total sale of $4,090,926. Following the sale, Forminard directly owned 16,994 shares of JNJ stock, valued at $4,367,458.

The transaction represents a 48.37% decrease in Forminard's ownership of JNJ stock. The company recently announced a quarterly dividend of $1.34 per share, paid on September 8th to shareholders of record as of August 25th. This dividend payout ratio is 62.11%, with the firm's market capitalization standing at approximately $624.23 billion.

Johnson & Johnson has seen its stock price rise to $259.03 after trading up $2.05 on Friday, with a trading volume of 6,529,145 shares compared to its average volume of 8,388,591. The company's pharmaceuticals business focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology, and neuroscience.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc